Sijumon Kunjachan

An 2016 interview with Sijumon Kunjacha, PhD, of the Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School discusses his study of a dual-targeting strategy to specifically amplify damage in the tumor neoendothelium. The resulting tumor vascular disruption substantially improved the therapeutic outcome than targeting the cells alone